It takes about a year for people with focal epilepsy to start finding some relief from anti-seizure medications, a new study says. In all, 3 of 5 epilepsy patients (60%) do achieve freedom from ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...

Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists, which have gained popularity for treating type 2 diabetes and obesity, have been shown to have the surprising secondary ...